Check out your Company Bowl for anonymous work chats.
In October senior leaders met at Talent & Leadership Connect Houston, a cross-functional meeting of LivaNova’s international leaders from the U.S., Canadian and LATAM. They engaged and collaborated on key strategic topics such as innovation, inclusivity, customer centricity, transformation, talent and strategy. The Board of Directors and Executive Leadership Team members attended select items on the agenda, giving participants an opportunity to discuss global enterprise viewpoints and sharpen strategic insights. Participants created meaningful connections, met new colleagues and strengthened existing relationships, and we’re grateful to both organizers and attendees for making this event a success. #WeAreLivaNova #WorkThatMatters
Looking for your next job? We’ve just launched a new platform for jobseekers. Learn about our global business and discover our team culture, then search and apply to current vacancies. Find out if you’re a cultural fit, sign up for job alerts, and join the talent pool to get noticed by our recruiters. Why wait? Join us, and do work that matters. #WeAreHiring #WeAreLivaNova #WorkThatMatters #FollowYourPurpose
As a healthcare company committed to improving the lives of patients around the world, LivaNova is closely monitoring the coronavirus situation and is reacting accordingly as the issues evolve.
LivaNova to Present at the Baird 2020 Global Healthcare Conference
Great news for patients: We announced that CMS accepted the LivaNova protocol for the RECOVER clinical study (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression). Our CEO Damien McDonald said, “Now that the RECOVER study protocol has been finalized, we are ready to activate sites that will enroll patients in this important study. Those who suffer from depression that is difficult to treat may gain access through this study to a potentially life-altering treatment option. With depression as the leading cause of disability in the U.S., Medicare coverage is vital for these patients.” Enrollment is expected to begin in late 2019 and will include up to 500 unipolar and up to 500 bipolar patients at a maximum of 100 sites in the United States. http://glassdoor.com/slink.htm?key=vMcsO
LivaNova's cannulae digital hub is live. Discover new content and materials in one spot. http://glassdoor.com/slink.htm?key=vQBet
LivaNova is a proud sponsor of the American Association for Thoracic Surgery (AATS) Centennial meeting in Boston, April 29 – May 3. New data for the Perceval sutureless valve - in clinical use for a decade - will be unveiled. Visit us at booth #1622
